Bristol-Myers Squibb Co Stock Forecast for 2023 - 2025 - 2030
Updated on 02/01/2023
Stock Rating
2
Price Target
$83.00
Consensus
Outperform
Upside
14.47%
Analysts
0
Stock Rating
2
Upside
14.47%
Analysts
0
Price Target
$83.00
Bristol-Myers Squibb Co Stock Forecast and Price Target
If the average 2023 price target of $83.00 recently set by prominent experts for Bristol-Myers Squibb Co is met, there would be a potential upside of approximately 14.47% from the last closing price in January, 2023. The high estimate is $95.00, and the low is $60.00. If you're looking for information on Bristol-Myers Squibb Co stock, consider checking out the forecasts for comparable firms such as NasdaqGS:REGN.
$83.00
14.47% Upside
Outperform
2023 Fair Value Forecast
$123.45
2024 Fair Value Forecast
$127.65
2025 Fair Value Forecast
$133.35
2026 Fair Value Forecast
$127.95
2027 Fair Value Forecast
$123.75
2028 Fair Value Forecast
$118.95
2029 Fair Value Forecast
$108.90
2030 Fair Value Forecast
$102.75
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| JNJ Stock Forecast | Johnson & Johnson | Outperform |
11
|
$163.42 | $181.05 | 10.45% |
| LLY Stock Forecast | Eli Lilly and | Outperform |
16
|
$344.15 | $333.19 | 16.23% |
| PFE Stock Forecast | Pfizer Inc | Outperform |
3
|
$44.16 | $53.97 | 19.23% |
| VRTX Stock Forecast | Vertex Pharmaceuticals Inc | Outperform |
16
|
$323.10 | $323.74 | 0.90% |
| ZTS Stock Forecast | Zoetis | Buy |
18
|
$165.49 | $207.87 | 23.87% |
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| ALNY Stock Forecast | Alnylam Pharmaceuticals | Outperform |
7
|
$226.40 | $244.18 | 10.87% |
| BAX Stock Forecast | Baxter International | Outperform |
17
|
$45.69 | $62.83 | 26.94% |
| VTRS Stock Forecast | Viatris | Outperform |
8
|
$12.15 | $13.70 | 11.11% |
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| UTHR Stock Forecast | United Therapeutics | Outperform |
12
|
$263.17 | $279.92 | 12.09% |
| CTLT Stock Forecast | Catalent | Outperform |
15
|
$53.55 | $76.00 | 36.32% |
| IONS Stock Forecast | Ionis Pharmaceuticals | Outperform |
9
|
$39.87 | $52.42 | 25.41% |
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| CYTK Stock Forecast | Cytokinetics | Outperform |
10
|
$42.45 | $62.07 | 41.34% |
| BCPC Stock Forecast | Balchem | Outperform |
18
|
$130.63 | $163.67 | 25.55% |
| NEOG Stock Forecast | Neogen | Hold |
16
|
$21.42 | $37.00 | 19.05% |
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| CORT Stock Forecast | Corcept Therapeutics | Outperform |
16
|
$22.86 | $0.00 | 29.05% |
| INDV Stock Forecast | Indivior PLC | Buy |
14
|
£182.10 | £3.79 | -97.40% |
| PCRX Stock Forecast | Pacira BioSciences | Outperform |
16
|
$39.25 | $79.67 | 98.73% |
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| AMPH Stock Forecast | Amphastar Pharmaceuticals | Outperform |
14
|
$30.25 | $41.00 | 45.45% |
| IRWD Stock Forecast | Ironwood Pharmaceuticals | Hold |
14
|
$11.52 | $12.60 | 8.51% |
| SUPN Stock Forecast | Supernus Pharmaceuticals | Outperform |
16
|
$41.02 | $35.50 | -17.11% |
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| LGND Stock Forecast | Ligand Pharmaceuticals | Outperform |
14
|
$69.70 | $195.43 | 127.40% |
| MDGL Stock Forecast | Madrigal Pharmaceuticals | Outperform |
4
|
$288.07 | $170.08 | -39.25% |
| USNA Stock Forecast | USANA Health Sciences | Hold |
14
|
$58.44 | $104.00 | -2.46% |
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| NasdaqCM:ARPO Stock Forecast | Aerpio Pharmaceuticals | - |
6
|
$27.92 | $0.00 | 10.35% |
| CPRX Stock Forecast | Catalyst Pharmaceuticals | Outperform |
16
|
$15.49 | $10.95 | -22.53% |
| TGTX Stock Forecast | TG Therapeutics | Outperform |
9
|
$15.23 | $73.38 | 24.75% |